MedKoo Cat#: 326720 | Name: Clemizole HCl
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Clemizole, also known as AL 20, P 48, or Reactrol, is a potent inhibitor of transient receptor potential channel TRPC5. Clemizole efficiently blocks TRPC5 currents and Ca(2+) entry in the low micromolar range (IC50 = 1.0-1.3 µM). Clemizole blocks TRPC5 currents irrespectively of the mode of activation. Based on fluorometric [Ca(2+)]i measurements, clemizole exhibits a sixfold selectivity for TRPC5 over TRPC4β (IC50 = 6.4 µM). Clemizole was not only effective in blocking heterologously expressed TRPC5 homomers but also TRPC1:TRPC5 heteromers as well as native TRPC5-like currents in the U-87 glioblastoma cell line.

Chemical Structure

Clemizole HCl
Clemizole HCl
CAS#1163-36-6 (HCl)

Theoretical Analysis

MedKoo Cat#: 326720

Name: Clemizole HCl

CAS#: 1163-36-6 (HCl)

Chemical Formula: C19H21Cl2N3

Exact Mass: 0.0000

Molecular Weight: 362.30

Elemental Analysis: C, 62.99; H, 5.84; Cl, 19.57; N, 11.60

Price and Availability

Size Price Availability Quantity
25mg USD 120.00 Ready to ship
50mg USD 195.00 Ready to ship
100mg USD 350.00 Ready to ship
200mg USD 550.00 Ready to ship
500mg USD 1,230.00 Ready to ship
1g USD 2,150.00 Ready to ship
2g USD 3,350.00 Ready to ship
Show More
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Clemizole hydrochloride; AL 20; AL20; AL-20; P 48; Allercur; Reactrol
IUPAC/Chemical Name
1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzo[d]imidazole hydrochloride
InChi Key
DNFMJYXRIMLMBZ-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H20ClN3.ClH/c20-16-9-7-15(8-10-16)13-23-18-6-2-1-5-17(18)21-19(23)14-22-11-3-4-12-22;/h1-2,5-10H,3-4,11-14H2;1H
SMILES Code
ClC1=CC=C(C=C1)CN2C3=CC=CC=C3N=C2CN4CCCC4.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, DMF, ethanol, and water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Related: 1163-36-6 (Clemizole HCl) 442-52-4 (Clemizole free).
Biological target:
The IC50 of clemizole HCl for RNA binding by NS4B is 24 nM, whereas its EC50 for viral replication is 8 µM.
In vitro activity:
Clemizole efficiently blocked TRPC5 currents and Ca(2+) entry in the low micromolar range (IC50 = 1.0-1.3 µM). Clemizole blocked TRPC5 currents irrespectively of the mode of activation, for example, stimulation of G protein-coupled receptors, hypo-osmotic buffer conditions, or by the direct activator riluzole. Reference: Mol Pharmacol. 2014 Nov;86(5):514-21. https://pubmed.ncbi.nlm.nih.gov/25140002/
In vivo activity:
Clemizole effectively reduced the changes in glomerular permeability in rats caused by Ang II, similar to Ang II blocking. Clemizole had no significant effect on glomerular filtration rate (GFR) or Ang II-mediated increase in mean arterial pressure (ΔMAP). Reference: Physiol Rep. 2021 May;9(10):e14781. https://pubmed.ncbi.nlm.nih.gov/34042270/
Solvent mg/mL mM
Solubility
DMSO 21.7 59.81
DMSO:PBS (pH 7.2) (1:2) 0.3 0.83
DMF 5.0 13.80
Ethanol 2.0 5.52
Water 20.0 55.20
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 362.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Jie LJ, Wu WY, Li G, Xiao GS, Zhang S, Li GR, Wang Y. Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells. Br J Pharmacol. 2017 Feb;174(3):254-266. doi: 10.1111/bph.13679. Epub 2017 Jan 12. PMID: 27886373; PMCID: PMC5241390. 2. Richter JM, Schaefer M, Hill K. Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5. Mol Pharmacol. 2014 Nov;86(5):514-21. doi: 10.1124/mol.114.093229. Epub 2014 Aug 19. PMID: 25140002. 3. Dolinina J, Rippe A, Öberg CM. Clemizole and La3+ salts ameliorate angiotensin II-induced glomerular hyperpermeability in vivo. Physiol Rep. 2021 May;9(10):e14781. doi: 10.14814/phy2.14781. PMID: 34042270; PMCID: PMC8157770. 4. Grone BP, Qu T, Baraban SC. Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1lab Model of Dravet Syndrome. eNeuro. 2017 Aug 14;4(4):ENEURO.0066-17.2017. doi: 10.1523/ENEURO.0066-17.2017. PMID: 28812061; PMCID: PMC5555352.
In vitro protocol:
1. Jie LJ, Wu WY, Li G, Xiao GS, Zhang S, Li GR, Wang Y. Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells. Br J Pharmacol. 2017 Feb;174(3):254-266. doi: 10.1111/bph.13679. Epub 2017 Jan 12. PMID: 27886373; PMCID: PMC5241390. 2. Richter JM, Schaefer M, Hill K. Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5. Mol Pharmacol. 2014 Nov;86(5):514-21. doi: 10.1124/mol.114.093229. Epub 2014 Aug 19. PMID: 25140002.
In vivo protocol:
1. Jie LJ, Wu WY, Li G, Xiao GS, Zhang S, Li GR, Wang Y. Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells. Br J Pharmacol. 2017 Feb;174(3):254-266. doi: 10.1111/bph.13679. Epub 2017 Jan 12. PMID: 27886373; PMCID: PMC5241390. 2. Richter JM, Schaefer M, Hill K. Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5. Mol Pharmacol. 2014 Nov;86(5):514-21. doi: 10.1124/mol.114.093229. Epub 2014 Aug 19. PMID: 25140002.
1: Kumaş-Kulualp M, Gepdiremen A, Karataş E, Eşrefoğlu M. Clemizole hydrochloride, a potent TRPC5 calcium channel inhibitor, prevents cisplatin- induced nephrotoxicity in Spraque-Dawley rats. J Biochem Mol Toxicol. 2023 Jul;37(7):e23372. doi: 10.1002/jbt.23372. Epub 2023 Apr 26. PMID: 37102204. 2: Moog M, Baraban SC. Clemizole and trazodone are effective antiseizure treatments in a zebrafish model of STXBP1 disorder. Epilepsia Open. 2022 Sep;7(3):504-511. doi: 10.1002/epi4.12604. Epub 2022 May 17. PMID: 35451230; PMCID: PMC9436285. 3: Kobaisi F, Sulpice E, Barette C, Fayyad N, Fauvarque MO, Badran B, Fayyad- Kazan M, Fayyad-Kazan H, Gidrol X, Rachidi W. Isoconazole and Clemizole Hydrochloride Partially Reverse the Xeroderma Pigmentosum C Phenotype. Int J Mol Sci. 2021 Jul 29;22(15):8156. doi: 10.3390/ijms22158156. PMID: 34360928; PMCID: PMC8346964. 4: Dolinina J, Rippe A, Öberg CM. Clemizole and La3+ salts ameliorate angiotensin II-induced glomerular hyperpermeability in vivo. Physiol Rep. 2021 May;9(10):e14781. doi: 10.14814/phy2.14781. PMID: 34042270; PMCID: PMC8157770. 5: Griffin A, Hamling KR, Knupp K, Hong S, Lee LP, Baraban SC. Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome. Brain. 2017 Mar 1;140(3):669-683. doi: 10.1093/brain/aww342. PMID: 28073790; PMCID: PMC6075536. 6: Jie LJ, Wu WY, Li G, Xiao GS, Zhang S, Li GR, Wang Y. Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells. Br J Pharmacol. 2017 Feb;174(3):254-266. doi: 10.1111/bph.13679. Epub 2017 Jan 12. PMID: 27886373; PMCID: PMC5241390. 7: Richter JM, Schaefer M, Hill K. Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5. Mol Pharmacol. 2014 Nov;86(5):514-21. doi: 10.1124/mol.114.093229. Epub 2014 Aug 19. PMID: 25140002. 8: Vlahakis JZ, Vukomanovic D, Nakatsu K, Szarek WA. Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position. Bioorg Med Chem. 2013 Nov 1;21(21):6788-95. doi: 10.1016/j.bmc.2013.07.050. Epub 2013 Aug 8. PMID: 24021581. 9: Baraban SC, Dinday MT, Hortopan GA. Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment. Nat Commun. 2013;4:2410. doi: 10.1038/ncomms3410. PMID: 24002024; PMCID: PMC3891590. 10: Einav S, Sobol HD, Gehrig E, Glenn JS. The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors. J Infect Dis. 2010 Jul 1;202(1):65-74. doi: 10.1086/653080. PMID: 20486856; PMCID: PMC3008401. 11: Martinez-Mir I, Estañ L, Rubio E, Morales-Olivas FJ. Antihistaminic and anticholinergic activities of mequitazine in comparison with clemizole. J Pharm Pharmacol. 1988 Sep;40(9):655-6. doi: 10.1111/j.2042-7158.1988.tb05331.x. PMID: 2907038. 12: Belal S, Elsayed MA, Abdel-Hamid ME, Abdine H. Utility of chloranil in assay of naphazoline, clemizole, penicillin G sodium, and piperazine. J Pharm Sci. 1981 Feb;70(2):127-30. doi: 10.1002/jps.2600700204. PMID: 6110697. 13: Atay O, Türeli F, Celebioğlu A, Yazan Z. Clemizole'un bir pomad kombinasyonunda hexachlorophene ve hydrocortisone yaninda ince tabaka kromatografisi yöntemi ile teşhis ve miktar tayini [Method for the identification and quantitative determination, by thin-layer chromatography, of clemizole in a combination ointment of hexachlorophene and hydrocortisone]. Turk Hij Tecr Biyol Derg. 1978;38(1-3):28-36. Turkish. PMID: 38545. 14: Kleinhans D. Blutspiegel-Untersuchungen zur Frage der Depotwirkung von Clemizol-Penicillin G bei antiluischer Therapie [Blood level studies on the depot effect of clemizole-penicillin G in antiluetic therapy]. Z Haut Geschlechtskr. 1971 Jun 1;46(11):359-65. German. PMID: 4397107. 15: Cardenas L, Ruipérez JA, Hermosillo JA, Kabela E, Méndez R. Sur le traitement du flutter auriculaire par mouvement circulaire (emploi d'un antihistaminique: Clemizole) [Treatment of circular movement auricular flutter (the use of an antihistaminic: clemizole)]. Arch Mal Coeur Vaiss. 1969 Mar 3;62(3):401-11. French. PMID: 4396674. 16: Mendez R, Kabela E, Pastelin G, Martínez-López M, Sánchez-Pérez S. Antiarrhythmic actions of clemizole as pharmacologic evidence for a circus movement mechanism in atrial flutter. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1969;262(3):325-36. doi: 10.1007/BF00538434. PMID: 4388778. 17: Jubelin J, de Lumley L, Raybaud A. Exploration des conséquences allergiques éventuelles de l'emploi de Clémizole-Pénicilline [Exploration of the possible allergic consequences of utilization of clemizole-penicillin]. Mars Med. 1968;105(2):189-92. French. PMID: 4391633. 18: Cárdenas M, Ruipérez JA, Hermosillo A, Kabela E, Méndez R. El antihistaminico clemizole en el flutter auricular por movimiento circular [The antihistaminic clemizole in auricular flutter caused by circular movement]. Arch Inst Cardiol Mex. 1967 May-Jun;37(3):380-7. Spanish. PMID: 4383385. 19: Keller H. Verblüffende Wirkung von Clemizol-Penicillin G (Antihistamin- Penicillin-G in drei Notfällen) [Astonishing effect of clemizole-penicillin G (antihistamine-penicillin G in three emergencies)]. Landarzt. 1966 Jul 10;42(19):827-8. German. PMID: 4383488. 20: Bornemann K, Schulz E, Heinecker R. Akute, nichtallergische Reaktionen nach i.m. Gabe von Clemizol-Penicillin G und Streptomycin [Acute, non-allergic reactions following i.m. administration of clemizole-penicillin G and streptomycin]. Munch Med Wochenschr. 1966 Apr 15;108(15):834-7. German. PMID: 4383676.